Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development

被引：23
|
作者：
Hargrove-Grimes, Passley [1 ]
Low, Lucie A. [1 ]
Tagle, Danilo A. [1 ]
机构：
[1] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA
来源：
CELLS TISSUES ORGANS | 2022年 / 211卷 / 03期
关键词：
Microphysiological systems; Microfluidics; Bioengineering; Induced pluripotent stem cells; Drug development; ON-A-CHIP; PLURIPOTENT STEM-CELLS; PHARMACEUTICAL-INDUSTRY; SAFETY ASSESSMENT; ORGANS; DEVICES; MODELS; ABSORPTION; INDUCTION; EFFICACY;
D O I：
10.1159/000517422
中图分类号：
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号：
100101 ;
摘要：
Microphysiological systems (MPS) or tissue chips/organs-on-chips are novel in vitro models that emulate human physiology at the most basic functional level. In this review, we discuss various hurdles to widespread adoption of MPS technology focusing on issues from multiple stakeholder sectors, e.g., academic MPS developers, commercial suppliers of platforms, the pharmaceutical and biotechnology industries, and regulatory organizations. Broad adoption of MPS technology has thus far been limited by a gap in translation between platform developers, end-users, regulatory agencies, and the pharmaceutical industry. In this brief review, we offer a perspective on the existing barriers and how end-users may help surmount these obstacles to achieve broader adoption of MPS technology.
引用
收藏
页码：269 / 281
页数：13
相关论文
共 50 条
  • [31] Recent advancements in microphysiological systems for neural development and disease
    Nichols, Kyla
    Koppes, Ryan
    Koppes, Abigail
    [J]. CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2020, 14 : 42 - 51
  • [32] The development of an intestinal microphysiological system to model oral drug disposition
    Arian, Christopher M.
    Kelly, Edward J.
    Thummel, Kenneth E.
    [J]. FASEB JOURNAL, 2022, 36
  • [33] The development of an intestinal microphysiological system to model oral drug disposition
    Arian, Christopher M.
    Kelly, Edward J.
    Thummel, Kenneth E.
    [J]. FASEB JOURNAL, 2022, 36
  • [34] Applications of Microphysiological Systems to Disease Models in the Biopharmaceutical Industry: Opportunities and Challenges
    Irrechukwu, Onyi
    Yeager, Ronnie
    David, Rhiannon
    Ekert, Jason
    Saravanakumar, Anitha
    Choi, Colin K.
    [J]. ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2023, 40 (03) : 485 - 518
  • [35] Microphysiological systems composed of human organoids in microfluidic devices: advances and challenges
    Marin, Talita Miguel
    Pagani, Eduardo
    [J]. VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2018, 6 (02): : 74 - 91
  • [36] Opportunities and challenges with microphysiological systems: a pharma end-user perspective
    Ewart, Lorna
    Roth, Adrian
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (05) : 327 - 328
  • [37] Navigating autonomous demand responsive transport: stakeholder perspectives on deployment and adoption challenges
    Golbabaei, Fahimeh
    Paz, Alexander
    Yigitcanlar, Tan
    Bunker, Jonathan
    [J]. INTERNATIONAL JOURNAL OF DIGITAL EARTH, 2024, 17 (01)
  • [38] Microphysiological Systems ("Organs-on-Chips") for Drug Efficacy and Toxicity Testing
    Low, L. A.
    Tagle, D. A.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2017, 10 (04): : 237 - 239
  • [39] Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening
    Kurokawa, Yosuke K.
    George, Steven C.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2016, 96 : 225 - 233
  • [40] From microchannels to microphysiological systems: Development of application specific devices
    Yu, James
    Lim, Jungeun
    Choi, MunSeok
    Chung, Minhwan
    Jeon, Noo Li
    [J]. MICROELECTRONIC ENGINEERING, 2018, 202 : 9 - 18
12345